Skip to main content
MACH7 TECHNOLOGIES LIMITED logo

MACH7 TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · M7T ISIN · AU000000M7T0 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,192 across all filing types
Latest filing 2014-11-24 Capital/Financing Update
Country AU Australia
Listing ASX M7T

About MACH7 TECHNOLOGIES LIMITED

https://www.mach7t.com

Mach7 Technologies Limited specializes in enterprise imaging solutions for healthcare providers. The company develops software that enables the management, storage, and viewing of medical images and clinical data across diverse healthcare ecosystems. Its core offerings include the Mach7 Enterprise Imaging Platform, a Vendor Neutral Archive (VNA), and the eUnity Enterprise Viewer. These solutions are designed to provide a unified view of patient data, improving diagnostic workflows and clinical collaboration. Mach7's technology emphasizes interoperability, allowing integration with existing hospital systems and various imaging modalities. By decoupling data storage from viewing applications, the company offers a modular and scalable approach to medical data management, supporting large-scale healthcare networks and specialized diagnostic centers in optimizing their imaging infrastructure.

Recent filings

Filing Released Lang Actions
Prospectus 87 pages 1.7MB
Capital/Financing Update Classification · 95% confidence The document is titled as a "Prospectus" for an offer of new shares, detailing a public offer, priority offer, facilitation offer, vendor offer, and option offer. It discusses raising capital, acquisition of 3D Medical Limited, and compliance with ASX listing rules. The content includes investment overview, risk factors, details of the offers, and application forms. This is a detailed fundraising document aimed at investors to raise capital through share issuance. It is not a financial report, earnings release, or management discussion. It is a capital raising document, specifically a prospectus for a public offer of shares. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2014-11-24 English
Notice of General Meeting/Proxy Form 103 pages 1.3MB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'Notice of General Meeting and Explanatory Statement and Independent Expert’s Report and Proxy Form' and details resolutions to be voted on at a General Meeting scheduled for December 17, 2014. It includes multiple resolutions related to capital consolidation, share issues, changes in company activities, appointment of directors, and other corporate actions. The text is structured as a notice to shareholders with explanatory statements and proxy voting instructions. This type of document is typically sent to shareholders to inform them about the agenda and seek their votes at a general meeting. It is not a report of voting results, nor is it a full annual or interim financial report. It is also not a management discussion or earnings release. The presence of proxy forms and detailed resolutions confirms it is a Proxy Solicitation & Information Statement, which is designed to provide information and request votes for meetings.
2014-11-17 English
3D Medical Secures Exclusive Rights to Mach7 Technologies 2 pages 429.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 November 2014, detailing that 3D Medical Ltd has secured exclusive reseller rights to Mach7 Technologies. It includes highlights of the agreement, comments from the Chairman and CEO, and background information about 3D Medical Ltd. There are no financial statements, regulatory certifications, voting results, or management changes mentioned. The content is a corporate announcement about a business development or partnership rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a general regulatory announcement about a business update, which fits best under Regulatory Filings (RNS). The document length is 3835 characters, which is relatively short and consistent with an announcement rather than a full report.
2014-11-16 English
3D Medical Presentation November 2014 14 pages 1.1MB
Investor Presentation Classification · 95% confidence The document is titled '3D Medical Investor Presentation' and is described as a company presentation for 3D Medical Limited. It contains detailed information about the company's business model, products, market opportunity, future developments, directors, and capitalisation. The content is focused on providing investors with an overview of the company's strategy, technology, and market positioning. There are no financial statements or quarterly results presented, nor is this a regulatory announcement or a report publication notice. The document is clearly a presentation aimed at investors, consistent with the definition of an Investor Presentation (IP). The length of the document (over 14,000 characters) and the detailed content support this classification with high confidence.
2014-11-10 English
Appendix 4C - quarterly 5 pages 259.5KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and includes detailed financial data such as consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, payments to directors, reconciliation of cash, and compliance statements. The report covers a quarter ended 30 September 2014, indicating it is a quarterly financial report. The content is substantive with actual financial figures and analysis, not merely an announcement or certification. The document matches the characteristics of an Interim / Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. Q1 2015
2014-10-30 English
Notice of Annual General Meeting/Proxy Form 12 pages 472.5KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting and Explanatory Statement' for Safety Medical Products Limited. It includes details about the AGM date, location, agenda items such as receiving the annual financial reports, approval of the remuneration report, re-election of directors, and ratification of share issues. The document is a notice and explanatory statement sent to shareholders to inform them about the AGM and the resolutions to be voted on. It does not contain the actual annual report or financial statements but refers to them being considered at the meeting. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. The document length is substantial (15,000 characters), consistent with a detailed AGM notice and explanatory statement. Therefore, the correct classification is AGM Information (AGM-R).
2014-10-23 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.